CONMED (CNMD) Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings or view top-rated stocks.

5 analysts have issued 1-year price targets for CONMED's stock. Their CNMD share price forecasts range from $119.00 to $145.00. On average, they expect the company's share price to reach $135.67 in the next twelve months. This suggests a possible upside of 34.1% from the stock's current price.
View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts.

CONMED's stock was trading at $88.64 at the start of the year. Since then, CNMD stock has increased by 14.1% and is now trading at $101.15.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our CNMD earnings forecast.

CONMED Co. (NYSE:CNMD) posted its quarterly earnings data on Wednesday, July, 26th. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.79 by $0.04. The business earned $317.70 million during the quarter, compared to analyst estimates of $306.15 million. CONMED had a trailing twelve-month return on equity of 11.14% and a net margin of 7.75%. The firm's revenue was up 14.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.76 earnings per share.

CONMED announced a quarterly dividend on Thursday, August 10th. Shareholders of record on Friday, September 15th will be given a dividend of $0.20 per share on Thursday, October 5th. This represents a $0.80 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Thursday, September 14th.
Read our dividend analysis for CNMD.

ETFs with the largest weight of CONMED (NYSE:CNMD) stock in their portfolio include Small Cap US Equity Select ETF (RNSC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Xtrackers S&P SmallCap 600 ESG ETF (SMLE), SPDR S&P SmallCap 600 ESG ETF (ESIX), SPDR S&P 600 Small Cap ETF (SLY), Vanguard S&P Small-Cap 600 Value ETF (VIOV) and Vanguard S&P Small-Cap 600 ETF (VIOO).

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.79%. The dividend payout ratio is 28.27%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 18.31% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.

CONMED issued an update on its FY23 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of $3.40-$3.55 for the period, compared to the consensus EPS estimate of $3.42. The company issued revenue guidance of $1.23-$1.26 billion, compared to the consensus revenue estimate of $1.23 billion.

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

CONMED's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Capital Research Global Investors (8.04%), Earnest Partners LLC (7.23%), Champlain Investment Partners LLC (3.07%), Dimensional Fund Advisors LP (2.19%), Principal Financial Group Inc. (2.07%) and Geode Capital Management LLC (1.91%). Insiders that own company stock include Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends.

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNMD stock can currently be purchased for approximately $101.15.

CONMED (NYSE:CNMD) has a market capitalization of $3.11 billion and generates $1.05 billion in revenue each year. The company earns $-80,580,000.00 in net income (profit) each year or $2.83 on an earnings per share basis.

The company employs 4,100 workers across the globe.

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.